Enablex® (darifenacin) is a prescription medicine used in adults to treat the following symptoms of Overactive Bladder: a strong need to urinate with leaking or wetting accidents (“urge urinary incontinence”), a strong need to urinate right away (“urgency”), and having to urinate often (“urinary frequency”).
Important Safety Information for Enablex® (darifenacin) extended-release tablets
Enablex® is not for everyone. You should not take Enablex® if you are not able to empty your bladder (“urinary retention”), have delayed or slow emptying of your stomach (“gastric retention”), or have an eye problem called “uncontrolled narrow-angle glaucoma.”
Enablex® may cause allergic reactions that may be serious. If you have hives, skin rash, or swelling, severe itching, experience swelling of the face, mouth or tongue, or if you have trouble breathing, stop taking Enablex® and get medical help right away.
Medicines like Enablex® can cause blurred vision or dizziness. Tell your doctor if you experience confusion, hallucinations, fainting, or excessive sleepiness, particularly when beginning therapy or after an increase in dose. Do not drive or operate heavy machinery until you know how Enablex® affects you.
The most common side effects include dry mouth, constipation, headache, heartburn, nausea, urinary tract infection, blurred vision, heat exhaustion or heat stroke which can happen when Enablex® is used in hot environments. Symptoms of heat exhaustion may include: decreased sweating, dizziness, tiredness, nausea, and increased body temperature.
Tell your doctor about all of the medicines you take. Enablex® and certain other medicines may affect each other, causing side effects.
For more information, please see Full Prescribing Information and Patient Information.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Enablex® is a registered trademark of Warner Chilcott Company, LLC.